NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









LambdaVision

LambdaVision

Private
Woodbridge, ConnecticutHealthcare & Life Scienceshttps://www.lambdavision.com/

Last Round

Seed

Nov 5, 2025

Total Funding Raised

$20.29M

Company Overview

LambdaVision is a biotechnology company developing a protein-based artificial retina to restore meaningful vision for patients blinded by retinal degenerative diseases like retinitis pigmentosa and age-related macular degeneration.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Space Technology, Clinical Trials

Business Model

B2B

Customer Profile

Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

artificial retinaretinal implantbiomanufacturingmicrogravity manufacturingspace manufacturingin-space productionbacteriorhodopsinretinal degenerationbiotechmedical deviceInternational Space StationISSorbital manufacturingspace-based R&Dbio-printing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

LambdaVision Comparables

Compare LambdaVision with similar companies based on industry and business-model similarity.

LambdaVision comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

LambdaVision Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedNov 5, 2025
SeedMay 29, 2024
GrantJun 1, 2020
GrantApr 10, 2020
Series AOct 18, 2017
Pre Seed
Oct 4, 2011

Key People

Founding team and executive leadership

Nicole Wagner

Chief Executive Officer

Executive Team

LambdaVision Investors

Notable investors and investment history

LambdaVision investors
InvestorRounds
Connecticut InnovationsSeries A, Pre Seed
Seven Seven SixSeed
Aurelia Foundry FundSeed
E2MC VenturesSeed
Seraphim SpaceSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 11, 2025

    Developing a protein-based artificial retina using space for development.

LambdaVision Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

LambdaVision Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about LambdaVision's valuation, stock price, and market status.

Firmographic Details

HeadquartersWoodbridge, Connecticut
Employee Range12
Year Founded2009
Last FundingNov 5, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.